Disitamab Vedotin (RC48-ADC) in Breast Cancer
Clinical trial NCT05851677 · RECRUITING
Trial details
- NCT number
- NCT05851677
- Sponsor
- RenJi Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-01
- Primary completion
- 2027-03-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.